Etelcalcetide in Patients on Hemodialysis with Severe Secondary Hyperparathyroidism. Multicenter Study in “Real Life”

Etelcalcetide is a new calcimimetic indicated for the treatment of secondary hyperparathyroidism (SHPT) in dialysis patients. Etelcalcetide efficacy in SHPT has been ascertained only in randomized controlled trials. This multicenter study was carried out in “real world” setting that is different fro...

Full description

Saved in:
Bibliographic Details
Published in:J Clin Med
Main Authors: Russo, Domenico, Tripepi, Rocco, Malberti, Fabio, Di Iorio, Biagio, Scognamiglio, Bernadette, Di Lullo, Luca, Paduano, Immacolata Gaia, Tripepi, Giovanni Luigi, Panuccio, Vincenzo Antonio
Format: Artigo
Language:Inglês
Published: MDPI 2019
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6678718/
https://ncbi.nlm.nih.gov/pubmed/31330805
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm8071066
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items